This Amendment No. 12 (“Amendment No. 12”) to Schedule 13D amends the statement on Schedule 13D filed with the United States Securities and Exchange Commission on October 30, 2017, as amended by Amendment No. 1 thereto filed on August 28, 2018, Amendment No. 2 thereto filed on July 18, 2019, Amendment No. 3 thereto filed on September 8, 2022, Amendment No. 4 thereto filed on September 15, 2022, Amendment No. 5 thereto filed on January 9, 2023, Amendment No. 6 thereto filed on March 17, 2023, Amendment No. 7 thereto filed on May 24, 2023, Amendment No. 8 thereto filed on June 9, 2023, Amendment No. 9 thereto filed on June 30, 2023, Amendment No. 10 thereto filed on August 3, 2023 and Amendment No. 11 thereto filed on August 10, 2023 (collectively and as amended, the “Schedule 13D”), relating to the Common Stock. This Amendment No. 12 is being filed by Foris Ventures, LLC, Vallejo Ventures Trust, L. John Doerr, Ann Doerr, and Barbara Hager (collectively, the “Reporting Persons”).
The Items below amend the information disclosed under the corresponding Items of the Schedule 13D as described below. Except as specifically provided herein, this Amendment No. 12 does not modify any of the information previously reported in the Schedule 13D.
ITEM 4. PURPOSE OF TRANSACTION.
Item 4 of the Schedule 13D is supplemented by the following:
On September 13, 2023, the Company, Amyris Clean Beauty, Inc., and Aprinnova, LLC (collectively, the “Borrowers”), and certain other subsidiaries of the Company (the “Guarantors”) entered into an amendment (the “Amendment No. 1”) to that certain Senior Secured Super Priority Debtor In Possession Loan Agreement (the “DIP Credit Agreement”), dated as of September 13, 2023, by and among the Borrowers, Guarantors, each lender from time to time party to the DIP Credit Agreement and Euagore, LLC (an affiliate of Foris Ventures, LLC), in its capacity as administrative agent (the “Administrative Agent”). Pursuant to Amendment No. 1, the parties agreed, among other matters, to extend the Plan Support Deadline by fourteen calendar days from September 13, 2023 to September 27, 2023. In connection with Amendment No. 1, the Administrative Agent delivered the Consumer Brands Sale Toggle Event Notice, electing to require the Company to initiate a process to market and sell the Company’s Consumer Brand Business. Capitalized terms used herein that are not otherwise defined herein shall have the meanings given to them in the Amendment No. 1.
On September 19, 2023, the U.S. Bankruptcy Court for the District of Delaware entered a Second Interim DIP Order relating to the debtor-in-possession financing in the form of the DIP Credit Agreement (as amended by Amendment No. 1) to continue funding the operations of the Company. The Company expects a final hearing to take place on or about October 4, 2023 to consider entry of the Final DIP Order.
The foregoing does not purport to be complete and is qualified in its entirety by reference to the full text of Amendment No. 1 that is incorporated herein by reference to Exhibit PP.
General
On August 9, 2023 (the “Petition Date”), the Company and certain of its direct and indirect subsidiaries (collectively, the “Company Parties”) filed voluntary petitions for relief under Chapter 11 of Title 11 of the United States Code in the United States Bankruptcy Court for the District of Delaware (the “Bankruptcy Court”), thereby commencing Chapter 11 cases for the Company Parties (the “Chapter 11 Cases”). On the Petition Date, the Company Parties filed a motion with the Bankruptcy Court seeking to jointly administer the Chapter 11 Cases under the caption “In re: Amyris, et al.”
The Reporting Persons acquired the securities described in this Schedule for investment purposes and they intend to review their investments in the Company on a continuing basis. In addition, the Reporting Persons intend to participate in the management of the Company through representation on the Company’s board of directors (the “Board”). L. John Doerr and Ryan Panchadsaram, a partner at Foris Ventures, serve as members of the Board. Any actions the Reporting Persons might undertake will be dependent upon the Reporting Persons’ review of numerous factors, including, but not limited to: an ongoing evaluation of the Company’s business, financial condition, operations and prospects, including with respect to the Chapter 11 Cases; price levels of the Company’s securities; general market, industry and economic conditions; the relative attractiveness of alternative business and investment opportunities; and other future developments.